One of the leading causes of male infertility is defective sperm function, a pathology that commonly arises from oxidative stress in the germline. Lipid peroxidation events in the sperm plasma membrane result in the generation of cytotoxic aldehydes such as 4-hydroxynonenal (4HNE), which accentuate the production of reactive oxygen species (ROS) and cause cellular damage. One of the key enzymes involved in the metabolism of polyunsaturated fatty acids to 4HNE in somatic cells is arachidonate 15-lipoxygenase (ALOX15). Although ALOX15 has yet to be characterized in human spermatozoa, our previous studies have revealed a strong link between ALOX15 activity and the levels of oxidative stress and 4HNE in mouse germ cell models. In view of these data, we sought to assess the function of ALOX15 in mature human spermatozoa and determine whether the pharmacological inhibition of this enzyme could influence the level of oxidative stress experienced by these cells. By driving oxidative stress in vitro with exogenous H 2 O 2 , our data reveal that 6,11-dihydro[1]benzothiopyrano [4,3-b]indole (PD146176; a selective ALOX15 inhibitor) was able to significantly reduce several deleterious, oxidative insults in spermatozoa. Indeed, PD146176 attenuated the production of ROS, as well as membrane lipid peroxidation and 4HNE production in human spermatozoa. Accordingly, ALOX15 inhibition also protected the functional competence of these cells to acrosome react and bind homologous human zonae pellucidae. Together, these results implicate ALOX15 in the propagation of oxidative stress cascades within human spermatozoa and offer insight into potential therapeutic avenues to address male in fertility that arises from oxidative stress. Protection of human sperm against oxidative stress, 2018, Vol. 98, No. 6 
Introduction
Worldwide, as many as 15-20% of couples experience trouble conceiving [1] , with male factor infertility contributing to at least 40-50% of these cases [2] . In developed countries, it has been estimated that approximately 1 in 20 men are subfertile [3] . While the numerous contributing factors responsible for these figures are highly complex, male infertility has long been known to be associated with defective sperm function, rather than simply low cell number [4] . In this context, oxidative stress caused by elevated levels of intracellular reactive oxygen species (ROS) is recognized as a major contributing factor to a loss of sperm cell function [5] [6] [7] [8] [9] [10] . In a majority of somatic cells, sufficient cytosolic antioxidant mechanisms mitigate the potential for ROS overproduction. In contrast, the highly specialized cytodifferentiation process of spermiogenesis sees the cytoplasmic content of the developing male germ cell severely depleted [11, 12] . The concomitant loss of antioxidant defenses during this differentiation process [13] and the abundance of polyunsaturated fatty acids (PUFAs), which serve as major substrates for lipid peroxidation, place these cells at an increased risk of oxidative attack. The peroxidation cascades that ensue produce a wide range of physiologically and pathologically important products including cytotoxic aldehydes, which initiate further production of ROS, precipitating a loss in function and cell death [5, 7, 10, 14, 15] .
The metabolism of PUFAs to lipid aldehydes can be mediated by both nonenzymatic and enzymatic means [16] . In regard to the latter, we have recently used a mouse germline model to establish a causative link between the generation of the lipid aldehyde, 4-hydroxynonenal (4HNE), and the enzymatic action of arachidonate 15-lipoxygenase (ALOX15) [17] , a member of the non-heme iron-containing lipoxygenase family. Furthermore, this study confirmed that the pharmacological inhibition of ALOX15 was able to reduce both ROS levels and 4HNE production in an immortalized spermatocyte cell line [GC-2spd(ts)] [17] . Such evidence builds on work conducted in somatic cells where lipoxygenases have been well-documented to act as catalysts for lipid peroxidation [16, 18, 19] . Although a thorough mechanistic understanding of the functions of ALOX15 is yet to be established, its enzymatic action is dependent on the central redox-active iron atom, thereby promoting lipid peroxidation via hydrogen extraction and oxygenation of lipid substrates [16, 19] .
These observations are commensurate with compelling data obtained using transgenic mouse models, which have firmly implicated ALOX15 in the regulation of male fertility [20] . Specifically, Brütsch and colleagues exploited an elegant double knockout strategy to secure evidence that targeted deletion of the Alox15 gene could rescue a range of adverse sequelae associated with the accompanying loss of a single glutathione peroxidase 4 (Gpx4) allele. In wild-type animals, testicular GPX4 acts as an antioxidant enzyme owing to its ability to catalyze the reduction of hydrogen peroxide (H 2 O 2 ), organic hydroperoxides, and lipid peroxides at the expense of reduced glutathione. Deletion of even a single Gpx4 allele (i.e., genotype Gpx4 +/− ) leads to notable defects in sperm function observed through reduced motility (total, rapid, and progressive) and an attendant reduction in overall litter size [20] . In marked contrast, each of these functional attributes, as well as the overall fertility of the animals, were significantly improved in an equivalent transgenic mouse line that also harbored a complete ablation of the Alox15 gene (i.e., genotype Gpx4 +/− /Alox15 −/− ). Taken together, these data suggest that ALOX15 may hold a central role in the maintenance of redox status within the male reproductive system. While an equivalent role is yet to be explored in human spermatozoa, we postulate that ALOX15 may contribute to lipid peroxidation in these cells and that an elevation in its presence or activity may precipitate their oxidative demise. Given the prevalence of oxidative stress-induced dysfunction in the male germline, the present study sought to characterize the presence of ALOX15 in mature human spermatozoa and determine whether the selective inhibition of this lipoxygenase enzyme could reduce the levels of oxidative stress experienced by these cells.
Materials and methods

Ethical approval
The experiments described in this study were conducted using human semen samples obtained with informed consent from a panel of healthy normozoospermic donors. Routine assessment of semen parameters were conducted in accordance with WHO criteria [21] . All studies were performed in accordance with the University of Newcastle's Human Ethics Committee guidelines (Approval No. H-2013-0319).
Reagents
Unless specified, chemical reagents were obtained from Sigma Aldrich (St. Louis, MO, USA) and were of research grade. 6,11-dihydro [1] benzothiopyrano [4,3-b] indole (PD146176) was obtained from Tocris Bioscience (Avonmouth, Bristol, UK). Mitosox Red (MSR) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Fluorescent probes, dihydroethidium (DHE), LIVE/DEAD, BODIPY-C 11 , and SYTOX Green were also purchased from Thermo Fisher Scientific. Primary antibodies raised against ALOX15 and CD59 were purchased from Abcam (Cambridge, MA, USA). TrisHCl was purchased from ICN Biochemicals (Castle Hill, NSW, Australia) and nitrocellulose and Percoll were from GE Healthcare (Chicago, IL, USA). Mowiol 4-88 was from Calbiochem (La Jolla, CA, USA), with paraformaldehyde being supplied by ProSciTech (Thuringowa, QLD, Australia). All antibodies and details for their use are included in Supplementary Table S1 .
Preparation of human spermatozoa
Unless otherwise stated, all experimental procedures involving human spermatozoa were replicated at least three times, with each replicate consisting of spermatozoa obtained from at least one individual semen donor (i.e., at least n = 3 sperm donors). Enrichment of human spermatozoa was completed through the use of discontinuous Percoll gradients of (45%/90%) as previously described [5, 22] . Briefly, semen samples were layered on top of Percoll gradients and centrifuged at 500× g for 30 min. mM sodium lactate, 5 U/ml penicillin, 5 mg/ml streptomycin and 20 mM (4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N -(2-ethanesulfonic acid)) HEPES buffer and 1 mg/ml polyvinyl alcohol (osmolarity of 290-310 mOsm/kg). Following centrifugation, spermatozoa were resuspended in NC BWW at a concentration of 10 × 10 6 cells/ml.
Capacitation and acrosome reaction of human spermatozoa
In vitro induction of capacitation was implemented using a modified "capacitating" BWW media [24] . In addition to the base ingredients utilized in the preparation of BWW, the capacitating BWW was supplemented with the additional reagents of 25 mM NaHCO 3 , 3 mM pentoxifylline, and 5 mM dibutyryl cyclic adenosine monophosphate as previously described [5] . Sperm populations (10 × 10 6 cells/ml)
were incubated for 3 h in an atmosphere of 5% CO 2 /95% air at 37 o C. Following capacitation, induction of the acrosome reaction was effected using calcium ionophore A23187 (2.5 μM). [25] .
Immunocytochemistry
Noncapacitated and capacitated sperm populations were fixed using 4% paraformaldehyde and then washed with a 0.05 M glycine/phosphate-buffered saline (PBS) solution. Cells were settled onto poly-L-lysine coverslips and permeabilized using 0.2% Triton X-100 as previously described [17] . Slides were then blocked in 3% bovine serum albumin (BSA), and primary antibody incubations were completed using anti-ALOX15 antibodies (5 μg/ml) overnight at 4
• C. Appropriate secondary antibodies were applied for 1 h at room temperature before counter staining slides with PNA-TRITC (1 μg/μl) for 20 min. All coverslips were mounted onto glass slides using a 10% Mowiol anti-fade solution. ALOX15 labeling of spermatozoa was then examined using a Zeiss LSM510 laser scanning confocal microscope (Carl Zeiss). by a goat-anti-rabbit HRP-conjugated secondary antibody (used as above). Immunodetection was completed using an enhanced chemiluminescence detection kit (GE Healthcare) as per the manufacturer's instructions.
Surface labeling of human spermatozoa
The surface expression of ALOX15 was examined in noncapacitated and capacitated human sperm populations. Live populations of spermatozoa were labeled with the anti-ALOX15 antibody (5 μg/ml) for 30 min at 37
• C. The viability stain LIVE/DEAD (diluted 1:10 000) was added in the final 10 min of the primary antibody incubation. Following three washes in BWW, samples were incubated with the secondary antibody goat-anti-rabbit Alexa-Fluor 488 (15 min, 37
• C). A final BWW wash was completed, and surface expression was assessed on the live sperm populations using the FACSCanto flow cytometer (BD Biosciences, San Jose, CA, USA). An anti-CD59 antibody was used as a positive control for surface labeling due to its previously documented presence on the surface of human spermatozoa [27] . CD59 staining was completed using an anti-CD59 antibody (30 min at 37
• C) in combination with a goat-anti-mouse Alexa-Fluor 488 (15 min, 37
• C).
Inhibition of ALOX15 in human spermatozoa and the induction of oxidative stress
To selectively inhibit ALOX15 catalytic activity in human spermatozoa, the indole based inhibitor PD146176 was used as previously described [17] . PD146176 is a noncompetitive, ALOX15 specific inhibitor [28, 29] that has been demonstrated to significantly reduce 15-HPETE [30] and 13-HODE production [31] , both of which are major by-products of the ALOX15 metabolic pathway [32] . In pilot studies, we titrated effective doses of PD146176 based on the published IC 50 value of 0.54 μM [31] , and ensured that sperm viability was not compromised in the dose-response range of 0.25-2.5 μM (please see Supplementary Figure S1 ). Following this, noncapacitated sperm samples (10 × 10 6 cells/ml) were pretreated with PD146176
for 30 min at room temperature, and then exposed to H 2 O 2 as a means of inducing an oxidative insult. Hydrogen peroxide (Sigma; Downloaded from https://academic.oup.com/biolreprod/article-abstract/98/6/784/4931704 by OUP site access user on 08 October 2018 349887) was diluted in BWW media from a 35% solution to a working concentration of 179 mM. This solution was then added to sperm populations of 10 × 10 6 cells/ml to the experiment-dependent final concentration outlined below (between 0.2 and 1 mM) and incubated for 1 h at 37
• C. Following incubation, human spermatozoa were thoroughly washed free of H 2 O 2 via three centrifugation events at 500× g for 3 min and resuspension in fresh BWW media. Notably, as documented below, the H 2 O 2 treatment doses were varied between assays in accordance with previously established data concerning the efficacy of this insult to induce oxidative-stressrelated changes in different functional parameters of human spermatozoa [33] . Thus, due to the differing sensitivity of the MSR, DHE, and BODIPY-C 11 probes, the assessment of mitochondrial ROS was performed using 200 μM H 2 O 2 to induce an MSR response, while the assessment of cellular ROS and lipid peroxidation were performed using 1 mM H 2 O 2 to induce DHE and BODIPY-C 11 responses. For the analysis of sperm function following ALOX15 inhibition, a concentration of 500 μM H 2 O 2 was required before a marked change in sperm motility could be assessed. Taking this into consideration, the levels of H 2 O 2 employed to evaluate sperm capacitation parameters under conditions of oxidative stress were reduced to 200 μM as this mild level of oxidative insult was permissive of the assessment of sperm-zona pellucida (ZP) interaction independent of any significant impact on sperm motility. Notwithstanding these experimental necessities, a consistent concentration of 0.25 μM PD146176 was coadministered alongside the varied H 2 O 2 treatments in all assays.
ROS analysis
Mitochondrial and cellular ROS levels were established in ALOX15-inhibited sperm following exposure to H 2 O 2 . Mitochondrial ROS was examined using the MSR probe, which was incubated with sperm populations at a final concentration of 20 μM for the duration of oxidative treatments with the inclusion of a SYTOX Green vitality stain (50 nM). Following H 2 O 2 treatment, sperm samples were washed using NC BWW media, and mitochondrial ROS levels were assessed by fluorescence microscopy, recording the percentage of cells with a positive, red fluorescent signal for MSR. Similarly, cellular ROS was assessed using the DHE probe, which was used at a concentration of 2 μM (30 min, 37 o C) alongside SYTOX Green (50 nM). Cellular ROS assessment was then completed using fluorescence microscopy and recording those cells with red DHE incorporation as being positively labeled. Further, lipid peroxidation levels were measured using the BODIPY-C 11 probe (5 μM). This probe was preincubated with human sperm samples for 30 min at 37 o C prior to the induction to oxidative stress. Cells were then washed free from the probe, and oxidative stress was induced as described previously. At the completion of the assay, lipid peroxidation levels were measured using the flow cytometer.
Zona pellucida binding assessment of human spermatozoa
Sperm-ZP binding was assessed using salt-stored human ZP from immature oocytes donated by IVF Australia (as described in [5] ). Preservation of oocytes prior to analysis was achieved through immersion in a high salt storage medium comprising 1.5 M MgCl 2 , 0.1% dextran, 0.01 mM HEPES buffer, and 0.1% PVA at 4
• C.
Prior to use, oocytes were washed three times using PBS via serial aspiration. Oocytes were then placed within capacitating BWW droplets immersed in mineral oil and incubated in 5% CO 2 /95% air/37
• C for 30 min to enable the oocytes to equilibrate with the surrounding media. As homologous human ZP is an extremely limited resource, these experiments were performed as two independent replicates (n = 2) using four to six oocytes in each treatment group. The treatment groups utilized for analysis included a noncapacitated negative control, a capacitated positive control, a H 2 O 2 -treated control, and a PD146176/H 2 O 2 -treated sperm sample. Following PD146176/H 2 O 2 treatment, spermatozoa were capacitated as previously described, and the percentage of motile cells for each treatment group was recorded. Sperm populations were then diluted to a concentration of 1 × 10 6 cells/ml with a total of 2 × 10 5 cells (20 μl) being deposited into each oocyte-containing droplet. The human gametes were then coincubated for 30 min at 5% CO 2 /95% air/37
• C to allow sperm-ZP adhesion to occur. Following coincubation, oocytes were washed in triplicate and mounted on glass slides using coverslips supported by 80% paraffin wax and 20% Vaseline gel at each corner to prevent oocyte compaction. Motile spermatozoa bound to ZP were then counted, and representative images were taken for each treatment, using phase-contrast microscopy (Zeiss Axioplan 2).
Statistical analysis
In this paper, data are presented as mean values and accompanying standard error. JMP statistical software (SAS Institute Inc., Cary, NC, USA) was used for all statistical analysis using unpaired ttests, and the level of significance denoted by asterisks such that P < 0.05 ( * ), P < 0.01 ( * * ), and P < 0.005 ( * * * ). All statistical testing was completed across three biological replicates (with each replicate comprising spermatozoa obtained from at least one donor) with the exception of sperm-ZP interaction (individual sperm donors, n = 2). Further, the small sample size for zona-binding experimentation required nonparametric measures for statistical testing using the Kolmogorov-Smirnov test for analysis.
Results
Characterization of ALOX15 in human spermatozoa
The first aim of this study was to confirm the presence of ALOX15 in mature human sperm populations. This analysis was completed through the application of immunoblotting assays (Figure 1 ), immunocytochemistry (Figure 2A) , and flow cytometry analysis to determine the subcellular localization of ALOX15 in human spermatozoa ( Figure 2C ). Immunoblotting analysis with anti-ALOX15 antibodies confirmed that human spermatozoa do indeed harbor ALOX15 at the predicted molecular weight of ∼75 kDa (i.e., 74 804 Da; Figure 1A ). Band densitometry analysis, normalized against that of the α-tubulin loading control, confirmed no overt changes in the abundance of this protein in populations of noncapacitated versus capacitated spermatozoa ( Figure 1B ). Distinct localization of ALOX15 was detected within the anterior region of the sperm head and throughout the mid-and principal-piece of the flagellum, with no changes in the localization of this protein occurring in response to the induction of capacitation (Figure 2A) . Notably, in fixed and permeabilized spermatozoa, ALOX15 displayed strong colocalization with PNA, a marker of the outer acrosomal membrane [34] , thus confirming that this protein resides within the periacrosomal region of the sperm head and consistent with previous analyses in the human testis [17] .
The use of a sensitive flow cytometry assay confirmed that ALOX15 is unlikely to be superficially exposed on the exterior The intensity of protein labeling was determined using densitometric analyses, and the relative levels of ALOX15 were determined by normalization against the accompanying α-tubulin control. This experiment was replicated three times using individual human semen samples and representative immunoblots are included.
leaflet of the membrane of live human spermatozoa ( Figure 2C ). Indeed, in keeping with its cytosolic/inner membrane localization in somatic cells [35] , this assay revealed that ALOX15 is inaccessible to surface labeling in human spermatozoa irrespective of their capacitation status ( Figure 2C ). The specificity of this response was confirmed by labeling equivalent populations of spermatozoa with antibodies against CD59, a surface-expressed antigen [27] , employed as a positive control. Importantly, in this regard, all ALOX15 labeling was eliminated upon substitution of the anti-ALOX15 antibody with buffer alone (i.e., secondary antibody only control, Figure 2B and C).
The impact of ALOX15 inhibition on the generation of cellular ROS
Having established the presence of ALOX15 in human spermatozoa, we next sought to address the hypothesis that the activity of this lipoxygenase enzyme may be causally associated with oxidative stress and membrane lipid peroxidation in these cells. To dissect the involvement of ALOX15 in the oxidative stress cascade, human spermatozoa were coincubated with PD146176, a selective ALOX15 inhibitor, alongside an exogenous H 2 O 2 challenge. In pilot studies, we titrated the dose of PD146176 to ensure that it did not adversely impact sperm viability. The PD146176 concentrations (0.25-2.5 μM) selected for use in this study were based on a combination of the inhibitor's IC 50 value of 0.54 μM [31] , and on our previously published studies in the developing germ cells of the mouse [17] . As expected, none of the doses examined in this study precipitated any significant loss in spermatozoa viability during the 1 h treatment regimen (Supplementary Figure S1) . Based on these observations, we selected a PD146176 concentration of 0.25 μM for all further analyses, including assessment of mitochondrial and cellular ROS production (using MSR and DHE probes, respectively) ( Figure 3A and B). As anticipated, the addition of an exogenous H 2 O 2 challenge initiated a significant (P < 0.005), 3.2-fold increase in the number of cells with a positive mitochondrial ROS (MSR) signal compared to the untreated control populations of spermatozoa ( Figure 3A) . Notably, however, exposure to PD146176 for the duration of H 2 O 2 treatment led to a significant (P < 0.01) attenuation of mitochondrial ROS. Indeed, this reduction amounted to an approximate halving of the number of spermatozoa producing excessive mitochondrial ROS. Importantly, these trends were mirrored in terms of cellular ROS production measured by DHE, with a 5.4-fold increase (P < 0.005) in the number of cells displaying a positive DHE signal following H 2 O 2 exposure, and for this same population, a significant 1.5-fold reduction (P < 0.05) in the number of DHE positive spermatozoa upon the pharmacological inhibition of ALOX15 ( Figure 3B ). Together, these data support the tenet that ALOX15 may be intrinsically linked to the propagation of oxidative stress in mature human spermatozoa. Accordingly, we next elected to focus on the cumulative levels of membrane lipid peroxidation generated following the combined PD146176/H 2 O 2 treatment regimen ( Figure 4A ). For this purpose, lipid peroxidation capacity was assessed using the BODIPY-C 11 probe, which upon peroxidation experiences a shift in fluorescence emission (i.e., from 590 to 510 nm), identifying lipid peroxidationpositive cells [36] . Measurement of BODIPY-C 11 signals using flow cytometry revealed that H 2 O 2 treatment resulted in a substantial, 12.3-fold increase in the number of spermatozoa affected by lipid peroxidation (P < 0.005). However, consistent with the ROS analysis reported above, the percentage of lipid peroxidation-positive spermatozoa was significantly reduced (P < 0.01) by approximately 1.6-fold when H 2 O 2 treatment was performed in the presence of PD146176. However, as with both mitochondrial and cytosolic ROS levels, ALOX15 inhibition did not completely return the number of sperm harboring lipid peroxidation to levels that were comparable to that of the untreated control levels. In this regard, the addition of a PD146176-alone control ruled out any possibility that PD146176 may have any positive contribution to the levels of cellular lipid peroxidation (Supplementary Figure S2) . As a final focus for these studies, the presence of 4HNE in human spermatozoa and the ability of this aldehyde to modify sperm proteins was assessed by immunoblotting with a specific anti-4HNE antibody. This analysis revealed a marked reduction in the presence of cellular 4HNE levels following The cells were then counterstained with the LIVE/DEAD vitality stain prior to being subjected to flow cytometry. For this analysis, a minimum of 10 000 cells were assessed using a flow cytometer. This analysis was performed three times (n = 3 different sperm donors), and data are depicted as mean ± SEM. * * * P < 0.005 compared to positive control (CD59) labeling.
ALOX15 inhibition ( Figure 4B ). These data were verified through band densitometry analysis relative to an anti-α-tubulin loading control, whereby a significant decrease in 4HNE was obtained in lysates of human sperm challenged with H 2 O 2 in the presence of PD146176 ( Figure 4C ). Additionally, the influence of H 2 O 2 on the expression of the ALOX15 protein itself was analyzed through immunoblotting of human sperm lysates (Supplementary Figure S3A) . As expected, no significant change in the expression profile of ALOX15 was detected between untreated and H 2 O 2 -exposed sperm cells (Supplementary Figure S3B) .
Assessment of the impact of ALOX15 inhibition on sperm function
In view of the favorable responses documented by attenuating the action of ALOX15 in human spermatozoa, we next elected to study the downstream implications of inhibiting ALOX15 activity on the functional parameters of spermatozoa. This study was underpinned by the hypothesis that a reduction in ROS generation and lipid peroxidation levels in human spermatozoa would counter the concomitant loss in the function of these cells, previously reported following oxidative challenge [5] . Initially, we focused on determining whether ROS-induced losses in sperm motility could be prevented through the inhibition of ALOX15. Analysis of overall sperm motility indicated a highly significant (P < 0.01), 1.4-fold decrease in the percentage of motile spermatozoa following H 2 O 2 exposure, as measured following the induction of capacitation. Notably, however, this detrimental effect was completely prevented, such that the percentage of motile cells was restored to statistically similar levels to that of untreated and vehicle controls, if the cells were supplemented with PD146176 for the duration of H 2 O 2 treatment ( Figure 5A) . Previously, we have demonstrated that the competence of sperm to both complete an acrosome reaction and engage in interactions with the outer vestments of the oocyte (i.e., the ZP) are highly sensitive to oxidative stress, with even low levels of ROS able to compromise these important facets of human sperm function [5] . In view of these findings, we sought to examine whether the inhibition of ALOX15 may afford a novel means by which to protect the functionality of spermatozoa against oxidative stress. For this purpose, we first evaluated the responsiveness of capacitated human spermatozoa to the induction of an acrosome reaction following exposure to a calcium ionophore agonist (i.e., A23187). Using fluorescently labeled PNA as a marker of acrosomal status ( Figure 5C ), we were able to document a significant (P < 0.05) 1.7-fold reduction in the number of capacitated sperm having completed an acrosome reaction following the initiation of oxidative stress by H 2 O 2 exposure ( Figure 5B ). The application of PD146176 was, however, able to restore acrosome reaction rates to levels that were indistinguishable from that of the capacitated control groups of spermatozoa.
In the final stage of this analysis, we repeated the oxidative stress induction regimen with a view to assess its impact on sperm μM H2O2 to induce oxidative stress alongside PD146176 treatment to achieve ALOX15 inhibition. The addition of the MSR probe throughout treatments allowed visualization of mitochondrial superoxide production, as recorded using fluorescence microscopy. (B) To assess cellular ROS using the fluorescent DHE probe human sperm samples were incubated with 1 mM H2O2 to induce oxidative stress alongside PD146176 treatment to achieve ALOX15 inhibition. Due to some degree of variability in the basal levels of MSR and DHE positivity recorded between sperm samples, all data were normalized against the values obtained in the positive control samples (i.e., H2O2-treated spermatozoa). This analysis was performed in triplicate (n = 3 different sperm donors), and data are depicted as mean ± SEM, P < 0.05 * , P < 0.01 * * , P < 0.005 * * * compared to H2O2 control. . Assessment of lipid peroxidation following H2O2 PD146176 treatment of human spermatozoa. Sperm samples were incubated with 1 mM H2O2 to induce oxidative stress and thereby promote lipid peroxidation alongside PD146176 treatment to achieve ALOX15 inhibition. (A) Sperm samples were incubated with BODIPY-C11 prior to H2O2 ± PD146176 treatments. They were subsequently assessed for relative levels of lipid peroxidation using flow cytometry. For this analysis, a minimum of 10 000 cells were assessed, and due to donor variability all data were normalized to the H2O2-treated control. (B) The presence of 4HNE in human spermatozoa following H2O2 ± PD146176 treatments was assessed by immunoblotting. Following treatment, samples were lysed with SDS extraction buffer prior to being resolved by SDS-PAGE and electrotransferred to nitrocellulose membranes. Membranes were sequentially probed with anti-4HNE and appropriate HRP-conjugated secondary antibodies. After visualizing labeled proteins, the membranes were stripped and reprobed with anti-α-tubulin antibodies to ensure equal protein loading. (C) The intensity of protein labeling was determined using densitometric analyses, and the relative levels of 4HNE were determined by normalization against the accompanying α-tubulin bands. This analysis was performed in triplicate (n = 3 different sperm donors), and data are depicted as mean ± SEM, P < 0.05 * , P < 0.01 * * , P < 0.005 * * * compared to H2O2 control.
adhesion to homologous ZP. In terms of the sequence for this assay, sperm were exposed to H 2 O 2 ± PD146176 prior to capacitation, assessed for motility, and placed in a droplet of saltstored oocytes. To negate any confounding influence on sperm motility, the concentration of H 2 O 2 used in this assay was reduced to a level at which motility was unaffected (i.e., 200 μM; Supplementary Figure S4) . Following the coincubation of the gametes, the number of motile sperm bound to the ZP was assessed revealing a significant reduction in ZP binding in the population exposed to H 2 O 2 alone (P < 0.05) ( Figure 6A and B). Excitingly, however, supplementation with PD146176 during H 2 O 2 treatment led to a complete rescue of sperm-ZP binding compared to the untreated capacitated control group ( Figure 6B and C).
Downloaded from https://academic.oup.com/biolreprod/article-abstract/98/6/784/4931704 by OUP site access user on 08 October 2018 Figure 5 . Motility assessment and acrosome reaction rates of human spermatozoa following H2O2 ± PD146176 treatment. (A) Sperm samples were incubated with 500 μM H2O2 to induce oxidative stress with or without PD146176. Sperm motility was then assessed for a minimum of 100 cells per treatments group using light microscopy and these data are expressed as the percentage of motile cells. (B) To induce the acrosome reaction, human spermatozoa samples exposed to 200 μM H2O2 were capacitated prior to incubation with a calcium ionophore, A23187. Following induction of the acrosome reaction, spermatozoa were incubated in HOS medium to distinguish the live cell population. (C) Representative PNA staining patterns were utilized to determine the acrosomal status of human spermatozoa. These analyses were performed in triplicate (n = 3 different sperm donors), and data are depicted as mean ± SEM, P < 0.05 * , P < 0.01 * * , P < 0.005 * * * compared to H2O2 control.
Discussion
The results of this study provide the first characterization of ALOX15 in human spermatozoa and indicate that a disruption in ALOX15 activity reduces ROS production and membrane lipid peroxidation. Consequently, ALOX15 inhibition may afford a degree of protection for human spermatozoa against exogenously induced oxidative stress and thus maintain the integrity of the maturational events required for fertilization.
In nonstimulated somatic cells such as those of the hematopoietic lineage, lipoxygenase enzymes commonly reside within the cytoplasm. However, upon receipt of an appropriate oxidative stimulus, these enzymes endure a calcium-dependent translocation leading to their binding to the inner leaflet of the plasma membrane whereupon they fulfill their roles in the lipid peroxidation process [35] . This localization profile is consistent with our own data indicating that ALOX15 is likely to reside in the inner leaflet of the human sperm plasma membrane but is not exposed on the cell surface. Such a position ideally places ALOX15 to participate in the degradation of its lipid substrates in the sperm plasma membrane. In somatic cells, this catalytic reaction proceeds via alternate oxidation and reduction of the iron atom contained within the protein's catalytic site [16] , thus facilitating the lipid peroxidation process and yielding a suite of secondary products including 4HNE. In line with this activity, the results outlined in this manuscript demonstrate a significant decrease in mitochondrial and cellular ROS in human spermatozoa exposed to PD146176 during oxidative challenge. Importantly, the attenuation of these ROS responses also led to a commensurate reduction in the overall degree of membrane lipid peroxidation experienced by spermatozoa. Downstream of lipid peroxidation, we also recorded a significant decrease in 4HNE, a reactive aldehyde that has previously been linked to a severe reduction in sperm motility [37] , sperm-egg recognition [5] , and the ability to complete an acrosome reaction [5] . Consistent with these findings, we have found that the pharmacological inhibition of ALOX15 and resulting decreases in 4HNE during conditions of cellular oxidative stress lead to a significant improvement in all three of these functional parameters. These data therefore establish a critical link between 4HNE-mediated cellular dysfunction and the action of the ALOX15 enzyme in human spermatozoa. In view of this understanding, we propose a mechanistic model for the function of ALOX15 in human spermatozoa and its relationship with cellular ROS production ( Figure 7 ). In line with our previous findings [6, 7, 10, 38, 39] , this model indicates that the propagation of oxidative stress in human spermatozoa is likely initiated through insults that elevate the production of superoxide (O 2 −. ) anions from within the mitochondrial electron transport chain (ETC). Here, we propose that the activation of ALOX15 under such conditions of oxidative stress catalyzes the degradation of PUFAs (i.e., arachidonic acid and linoleic acid) via redox cycling of the iron atom held within its catalytic domain. ALOX15 activity culminates in 4HNE production, which facilitates further ETC disruption causing unchecked cascades of ROS production, lipid peroxidation, and protein adduction. These combined events compromise the physiological status of the sperm cell, leading to a reduction in sperm binding to ZP.
The results described in this study on human spermatozoa are in agreement with our previously published work examining the role of ALOX15 in 4HNE-mediated protein damage in mouse GC-2 cells [17] . They are also congruous with the results obtained from elegant Gpx4 +/− /Alox15 −/− double knockout mouse models published by Brütsch and colleagues, which firmly implicate ALOX15 in the Figure 6 . Zona pellucida binding assessment following H2O2 ± PD146176 treatment of human spermatozoa. Sperm samples were incubated with 200 μM H2O2 to induce oxidative stress with or without PD146176. Sperm samples were washed free of H2O2 and capacitated for 3 h. (A) Sperm were coincubated with oocytes for 30 min, and the number of motile sperm bound to the ZP was counted using phase contrast microscopy and images were captured on a Zeiss-Axiovert fluorescence microscope (B). As a cautionary note, the limited availability of human oocytes restricted the replication of these analyses to two separate experiments (n = 2 individual sperm donors and four to six oocytes per treatment group). Data are depicted as mean ± SEM, P < 0.05 * , P < 0.01 * * , P < 0.005 * * * compared to H2O2 control.
subfertility observed in the Gpx4 +/− mouse line [20] . Thus, the inhibition of ALOX15 in the testis could present a novel therapeutic strategy for the prevention of oxidative stress-mediated pathologies in the male germline. However, important considerations for this approach will involve research targeted towards understanding the physiological role of lipoxygenase enzymes in both the developing and mature germ cells, as well as establishing the utility of PD146176 to reduce 4HNE production in vivo by first testing its ability to cross the blood-testis barrier. In view of these potential limitations, preclinical experiments are currently underway investigating the utility of inhibiting ALOX15 enzymatic activity (through the application of PD146176) to combat neurodegenerative diseases such as Alzheimer's [40, 41] , a disease in which 4HNE has been implicated in the initiation of neuronal cell death and the generation of amyloid ß plaques [42] [43] [44] . Furthermore, in vivo experiments seeking to evaluate the effect of PD146176 in mouse models of Alzheimer's disease have revealed significant improvements in memory deficits, accompanied by reduced production and deposition of amyloid ß, in PD146176-treated mice compared to their untreated counterparts. These data reveal the distinct possibility of using PD146176 as a therapeutic strategy to reduce the progression of diseases involving oxidative stress and 4HNE production [45] .
Overall, our experimental evidence confirmed the presence of ALOX15 in human spermatozoa and defined its specific cellular localization in the periacrosomal head, midpiece, and tail regions of these specialized cells. Moreover, the pharmacological inhibition of ALOX15 proved effective in rescuing numerous sperm functional parameters that would otherwise be severely compromised by oxidative stress. Taken together, these data suggest that ALOX15 is, at least in part, responsible for the peroxidation of membrane lipids that leads to the production of deleterious aldehydes such as 4HNE in human spermatozoa. Given the extensive damage that 4HNE causes to both proteins and DNA in the male germline, the therapeutic benefits in reducing lipid peroxidation and the production of this aldehyde within spermatozoa are clear. Considering the increasing numbers of men experiencing infertility tied to high levels of ROS and attendant poor DNA quality, further investigation into the role of the lipoxygenase protein family in regulating oxidative stress and sperm function may help to elucidate the complex molecular mechanisms surrounding ROS-mediated male infertility and provide further therapeutic strategies.
Supplementary data
Supplementary data are available at BIOLRE online. . Proposed model for ALOX15 activity within ROS production cascades of human spermatozoa. The propagation of oxidative stress in human spermatozoa is likely initiated through insults that elevate the production of superoxide (O2 −. ) anions from within the mitochondrial electron transport chain (ETC). Highly reactive O2 −. stimulates increased production of ROS such as hydrogen peroxide (H2O2) and peroxynitrite (ONOO − ), which can further disrupt the integrity of the ETC and accentuate ROS production. The ROS so produced may contribute to the activation of phospholipase (PLA) proteins, which facilitate the dissociation of PUFAs from the sperm plasma membrane. Upon activation of ALOX15 (presumably via Ca 2 + -dependent signaling), the enzyme may translocate to the inner leaflet of the plasma membrane, a position from which it can catalyze the degradation of PUFAs (i.e., arachidonic acid (AA) and linoleic acid (LA)) via redox cycling of the iron atom held within its catalytic domain. ALOX15 activity culminates in 4HNE production, which facilitates further ETC disruption causing unchecked cascades of ROS production, lipid peroxidation, protein adduction, and DNA damage. These combined events compromise the physiological status of the sperm cell, leading to a reduction in sperm binding to the zona pellucida and an attendant loss of fertility.
Supplementary Table S1 . Details of antibodies and molecular probes used throughout this study. Supplementary Figure S1 . Assessment of human sperm viability. Viability assessments were made using Eosin Y staining of human sperm populations following treatment of PD146176 at increasing concentrations (0.25-2.5 μM). Statistical analysis was completed using JMP software with error bars indicative of SEM (n = 3 different sperm donors). No significant differences (P > 0.05) were observed between treatment groups. Supplementary Figure S2 . Inhibitor-alone controls for BODIPY-C 11 analysis. PD146176 was added to human spermatozoa at a concentration of 0.25 μM, and the levels of lipid peroxidation were examined relative to both untreated and H 2 O 2 -exposed (1 mM) control samples. No significant difference in either sperm viability or the percentage of BODIPY-positive cells was observed between the untreated and inhibitor-alone sperm populations. Supplementary Figure S3 . Assessment of ALOX15 protein abundance. (A) Proteins from untreated and H 2 O 2 -treated (1 mM) human sperm samples were solubilized by lysing the cells in an SDSbased extraction buffer, prior to being resolved by SDS-PAGE and electrotransferred to nitrocellulose membranes. Membranes were sequentially probed with anti-ALOX15, and an appropriate HRPconjugated secondary antibody. After visualizing ALOX15 labeling, the membranes were stripped and reprobed with anti-α-tubulin antibodies to ensure equal protein loading. (B) Band densitometry was performed on 75 kDa bands ALOX15 bands relative to tubulin loading controls using Image J software.
Supplementary Figure S4 . Percentage of motile spermatozoa prior to gamete coincubation. Following capacitation, sperm motility was assessed for each treatment group, to ensure zona binding competence was not influenced by a loss of cell motility. Total motility was recorded as the percentage of motile cells using light microscopy. Data are presented as mean ± SEM. No significant differences were found between treatment groups.
